Drug eluting expandable devices
US9114125B2 · kind B2 · utility
3Cited by
19References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2008 |
| Grant date | Aug 25, 2015 |
| Priority date | — |
| Expiry date | Mar 2, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/802
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to drug eluting devices, and their uses. The drug eluting devices can allow for perfusion during deployment. The coatings the may contain bioactive materials which elute once deployed in a patient and can have anti-proliferative, anti-inflammation, or anti-thrombotic effects. Sol gel technology can be used to coat the devices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.